Address45 Qmbiz -Dokki - Giza - Egypt
Call us+201066508816
Contact us+201000970678
Write usinfo@dws-eg.com

Recent Comments

    Medical Page


    Medical sector in Egypt is one of the oldest strategic sectors in the country, founded in 1939 with the establishment of the Misr Company for Pharmaceutical Industries “Holdipharma”.
    Moreover, this strategy has succeeded in reaching an important measure to achieve self-sufficiency of the Egyptian medicine.
    Egypt paid great attention to the primacy of achieving self-sufficiency of the drug and has adopted policies targeting drug development various stages of the industry, both in the field of pharmaceutical raw materials and basic chemicals, manufacturing and packaging as well as for the marketing, sale and export. The Egyptian pharmaceutical industry market is divided into two main partners the state-owned companies, and the private sector partners represented in multinational companies as well as local companies. Multinational pharmaceutical and healthcare companies will find Egypt an attractive, yet challenging investment destination. Increasing political will in Egypt to develop the pharmaceutical and healthcare sector are a bright spot. Egypt’s pharmaceutical market is among the largest in MENA region, Egypt will remain the sixth largest pharmaceutical market in the MENA region in value terms, as well as retaining its top ten status in the wider Middle East Africa region. Due to the great diversity of products, local and foreign companies tend to specialize, thereby making the Egyptian pharmaceuticals market highly fragmented.
    On the other hand, Medical devices are challenging products to manufacture. The combination of regulatory requirements and life critical components make the development expensive and technically difficult.
    The first step to developing a medical device is identifying a user need in the target market. Minimizing the gap between the user’s needs and the designer’s perception of those needs is critical to creating a successful product.
    To assess user needs, start with these seven key questions:
    What will the device do?
    Who is going to use it?
    When will it be used?
    What are the most important features to consider?
    How will the user use this device?
    What are the clinical indications/applications for the device?
    Is the device single-use or multi-use?
    A strong development team is critical here — think experts in engineering and design, usability engineering, medicine, compliance, quality assurance, and intellectual property law. These partners will help answer these questions, ensure the concept is promising enough to pursue, and mitigate risk.
    This stage is also the time to lay the groundwork for the rest of the medical device design, development and manufacturing process. This includes coming up with timelines for the project at large as well as its individual stages, calculating potential revenue, gathering an understanding of the regulatory pathway ahead, assessing risk, and budgeting. Budgeting considerations can include funds for labor, materials, consulting, product testing, clinical trials, biocompatibility testing, and licenses and fees if the product will be released internationally.


    The Egyptian pharmaceutical industry has enjoyed a period of considerable development in recent years. There is a strong domestic production sector and, while the majority is destined for the domestic market and imports play an important role, Egypt has emerged as a leading exporter of pharmaceuticals to Arab, Asian and Eastern European markets.
    Public production, represented by the state-owned holding company HOLDIPHARMA; accounts for around one-tenth of sales by value and nearly two-tenths by volume. There are a number of leading local private producers, some of them involved in biotechnology, which are strengthening their capabilities.
    Experts agree that, the Egyptian pharmaceutical industry is very positive: Rapid population growth and expansion in healthcare cover­age and expenditures are key growth drivers, as are an increas­ing awareness of health issues and the modernization of the healthcare industry. Egypt has the largest drug –manufacturing base in the MENA region accounting for around 30% of the regional market. Local production covers around 93% of the market with 7% made up of highly specialized pharmaceuticals not produced locally.
    Multinational corporations account for about 30% of local sales through domestic manufacturing, and about 35% through licensing agreements, while the remaining ratio represents generic medicines produced by local companies.
    Medical Device overview:
    Innovation aims at solving problems, but which ones from an industry perspective. The Medical Device industry probably encompasses most, if not all, of the technology fields including (bio)chemistry, (bio)physics, biology, medicine, applied mathematics and computation, and of course manufacturing technology. In addition, industry standards are and must be extremely high for the safety of patients.


    The primary driver behind the high cost of new product development is the amount of time required to take an idea from conception to realization. By setting a solid foundation for a design project with clear and concise requirements specifications, these costs can be reduced, and organizations will realize faster “to-market” times and improved ROI.
    poor product quality can lead to serious end-user injuries or even death. While even the most basic medical devices face these challenges, newer, more technologically-advanced products are at an even greater risk.